← Leaderboards
Evelyn Attia
Columbia University Health Sciences
$8,164,685
Attributed
$9,703,463
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,703,463 · 8
By mechanism
R01$4,678,238 · 2
T32$2,189,006 · 1
R34$1,186,684 · 2
K23$800,499 · 1
R21$463,216 · 1
M01$385,820 · 1
Top collaborators
- B. Timothy Walsh15 shared
- Joanna E Steinglass2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Laurel Es Mayer$3,798,228
- Jay A Gingrich$13,464,959
- Diane A Klein$2,106,883
- Andrey Rzhetsky$12,458,207
- Noemie Elhadad$7,888,390
Others in their field
Top investigators on “Eating Disorders”
- Eric M Stice · University Of Texas Austin$27,856,807
- Terry L. Powley · Purdue University West Lafayette$24,896,460
- Carlos M Grilo · Yale University$23,768,687
- Loic Le Marchand · University Of Hawaii At Manoa$20,033,562
- Cynthia M Bulik · Virginia Commonwealth University$17,406,888
- Diego A. Pizzagalli · Harvard University$15,881,874
Research focus
Eating DisordersAnorexia NervosaBiobehaviorResearch TrainingRelapseHospitalsMorbidity - Disease RateProgramsTherapy DevelopmentRandomizedWeightBaseParticipantMonitorAdultAcuteClinical ResearchMental DisordersHydroxyindoleacetateBehaviorHuman SubjectAnxietyAntipsychotic AgentsInstitution
Grant awards (38)
Research Training in Biobehavioral Disturbances of Eating Disorders$170,168
T32 · FY2025 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$176,220
T32 · FY2024 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$242,165
T32 · FY2023 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$230,484
T32 · FY2022 · MH · contact PI
Optimizing Relapse Prevention and Changing Habits (REACH+) in Anorexia Nervosa$220,998
R34 · FY2022 · MH
Optimizing Relapse Prevention and Changing Habits (REACH+) in Anorexia Nervosa$287,293
R34 · FY2021 · MH
Research Training in Biobehavioral Disturbances of Eating Disorders$130,158
T32 · FY2021 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$257,768
T32 · FY2020 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$216,032
T32 · FY2019 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$54,412
T32 · FY2018 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$142,866
T32 · FY2017 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$768
T32 · FY2017 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$164,447
T32 · FY2016 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$195,988
T32 · FY2015 · MH · contact PI
Olanzapine Versus Placebo in Outpatients with Anorexia Nervosa$815,151
R01 · FY2014 · MH · contact PI
Research Training in Biobehavioral Disturbances of Eating Disorders$137,290
T32 · FY2014 · MH · contact PI
Olanzapine Versus Placebo in Outpatients with Anorexia Nervosa$827,341
R01 · FY2013 · MH · contact PI
Physical Activity in Anorexia Nervosa$380,259
R01 · FY2013 · MH
Research Training in Biobehavioral Disturbances of Eating Disorders$70,240
T32 · FY2013 · MH · contact PI
Olanzapine Versus Placebo in Outpatients with Anorexia Nervosa$858,134
R01 · FY2012 · MH · contact PI
Olanzapine Versus Placebo in Outpatients with Anorexia Nervosa$845,239
R01 · FY2011 · MH · contact PI
Olanzapine Versus Placebo in Outpatients with Anorexia Nervosa$952,114
R01 · FY2010 · MH · contact PI
Anorexia Nervosa: The Importance of Treatment Intensity$219,936
R34 · FY2007 · MH · contact PI
Anorexia Nervosa: The Importance of Treatment Intensity$226,503
R34 · FY2006 · MH · contact PI
Atypical Antipsychotic Medication in Anorexia Nervosa$153,228
R21 · FY2006 · MH · contact PI
Anorexia Nervosa: The Importance of Treatment Intensity$231,954
R34 · FY2005 · MH
SEROTONIN'S ROLE IN PSYCHOBIOLOGY OF ANOREXIA NERVOSA$166,647
K23 · FY2005 · MH
Atypical Antipsychotic Medication in Anorexia Nervosa$155,621
R21 · FY2005 · MH
SEROTONIN'S ROLE IN PSYCHOBIOLOGY OF ANOREXIA NERVOSA$163,291
K23 · FY2004 · MH
Atypical Antipsychotic Medication in Anorexia Nervosa$154,367
R21 · FY2004 · MH
SEROTONIN'S ROLE IN PSYCHOBIOLOGY OF ANOREXIA NERVOSA$160,033
K23 · FY2003 · MH
SEROTONERGIC ACTIVITY IN PATIENTS WITH ANOREXIA NERVOSA$192,910
M01 · FY2002 · RR
SEROTONIN'S ROLE IN PSYCHOBIOLOGY OF ANOREXIA NERVOSA$156,870
K23 · FY2002 · MH
SEROTONERGIC ACTIVITY IN PATIENTS WITH ANOREXIA NERVOSA$192,910
M01 · FY2001 · RR
SEROTONIN'S ROLE IN PSYCHOBIOLOGY OF ANOREXIA NERVOSA$153,658
K23 · FY2001 · MH
SEROTONERGIC ACTIVITY IN PATIENTS WITH ANOREXIA NERVOSA$0
M01 · FY2001 · RR
SEROTONERGIC ACTIVITY IN PATIENTS WITH ANOREXIA NERVOSA$0
M01 · FY2000 · RR
SEROTONERGIC ACTIVITY IN PATIENTS WITH ANOREXIA NERVOSA$0
M01 · FY2000 · RR